Quidel recommences shipments of QuickVue+ lateral flow diagnostic test for infectious mononucleosis

Jul 27 2010NewsGuard 100/100 Score

Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, announced today that it has begun taking orders for its QuickVue®+ lateral flow diagnostic test for infectious mononucleosis. Due to strong customer demand, the Company has restarted manufacturing its previous mononucleosis product with shipments to customers expected during the first week of August.

"Our end users have expressed a strong desire for us to bring back our IgM-specific QuickVue+ Infectious Mononucleosis test. This test will strengthen our existing QuickVue respiratory franchise, while leveraging our QuickVue manufacturing efficiencies." said Douglas Bryant, president and chief executive officer of Quidel Corporation.

This 5-minute test continues to deliver IgM specificity in a unique plus/minus format with high clinical sensitivity and specificity.

Source Quidel Corporation

Posted in: Device / Technology News | Disease/Infection News

Tags: , , , , , , , , , , ,

Comments (0)

Suggested Reading

Study warns of increasing Rocky Mountain spotted fever cases among children in California
Atlas maps plasma proteins to transform disease diagnosis and treatment
Progress in early detection and screening methods for pancreatic cancer
More than 100,000 young people in the US live with inflammatory bowel disease
AI-powered ECG model predicts heart disease risk with precision
AI outperforms doctors in diagnostics but falls short as a clinical assistant
New Alzheimer's guidelines focus on risk, not diagnosis, in healthy adults
Metagenomic sequencing improves detection of rare pathogens in CNS infections

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Why predictive retina models could be the future of IND applications